Analyst Price Target is $10.00
▲ +71.82% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Stereotaxis in the last 3 months. The average price target is $10.00, with a high forecast of $12.00 and a low forecast of $7.00. The average price target represents a 71.82% upside from the last price of $5.82.
Current Consensus is
The current consensus among 3 polled investment analysts is to buy stock in Stereotaxis.
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.